Thymus and mediastinal node involvement in childhood Langerhans cell histiocytosis: long-term follow-up from the French national cohort
Autor: | Ducassou, Stephane, Seyrig, Fanny, Thomas, Caroline, Lambilliotte, Anne, Marec-Berard, Perrine, Berger, Claire, Plat, Genevieve, Brugiere, Laurence, Ouache, Marie, Barkaoui, Mohamed, Armari-Alla, Corinne, Lutz, Patrick, Leverger, Guy, Rialland, Xavier, Mansuy, Ludovic, Pacquement, Helene, Jeziorski, Eric, Gandemer, Virginie, Chalard, François, Chateil, Jean François, Tazi, Abdellatif, Emile, Jean François, Donadieu, Jean, French LCH Study Group, Investigators |
---|---|
Přispěvatelé: | Hématologie et oncologie pédiatrique, Centre hospitalier universitaire de Nantes (CHU Nantes), Service d'hématologie pédiatrique-oncologie, Hôpital Jeanne de Flandre [Lille]-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Centre Léon Bérard [Lyon], service d'oncologie pédiatrique, Groupe d'Etude des Histiocytoses (GEH), Groupe d'Etude des Histiocytoses, Hôpital de la Tronche, Hôpital Civil, Hopital Civil, Service d'hématologie-immunologie-oncologie pédiatrique [CHU Trousseau], Université Pierre et Marie Curie - Paris 6 (UPMC)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-CHU Trousseau [APHP], Centre Robert Debré, Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM)-PRES Université Nantes Angers Le Mans (UNAM), Service d'Hématologie et d'Oncologie Pédiatrique [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Institut Curie, Système des phagocytes mononucléés et immunopathologie, Université Paris Descartes - Paris 5 (UPD5), Service de médecine de l'enfant et de l'adolescent, CHU Pontchaillou [Rennes]-Hôpital Sud, Service de pneumologie [Saint-Louis], Université Paris Diderot - Paris 7 (UPD7)-Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP), Service d'anatomie pathologique, Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpital Ambroise Paré, Centre de référence des Histiocytoses, Centre hospitalier universitaire de Nantes ( CHU Nantes ), Hôpital Jeanne de Flandre [Lille]-Centre Hospitalier Régional Universitaire [Lille] ( CHRU Lille ), Groupe d'Etude des Histiocytoses ( GEH ), Service d'hématologie-immunologie-oncologie pédiatrique, Université Pierre et Marie Curie - Paris 6 ( UPMC ) -Assistance publique - Hôpitaux de Paris (AP-HP)-CHU Trousseau [APHP], CHU Angers, Centre Hospitalier Régional Universitaire de Nancy ( CHRU Nancy ), Université Paris Descartes - Paris 5 ( UPD5 ), Assistance publique - Hôpitaux de Paris (AP-HP)-Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris]-Université Paris Diderot - Paris 7 ( UPD7 ), Université de Versailles Saint-Quentin-en-Yvelines ( UVSQ ) -Assistance publique - Hôpitaux de Paris (AP-HP)-Hôpital Ambroise Paré, Université Pierre et Marie Curie - Paris 6 (UPMC)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Trousseau [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), Institut Curie [Paris], CHU Pontchaillou [Rennes]-hôpital Sud, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Service d'anatomie pathologique [CHU Ambroise-Paré], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Ambroise Paré [AP-HP] |
Jazyk: | angličtina |
Rok vydání: | 2013 |
Předmět: |
Male
Pediatrics medicine.medical_specialty Pathology Langerhans cell Long term follow up [SDV]Life Sciences [q-bio] Thymus Gland 030218 nuclear medicine & medical imaging National cohort Cohort Studies 03 medical and health sciences 0302 clinical medicine Langerhans cell histiocytosis thymus medicine Humans survey mediastinal nodes Langerhans-Cell Child Preschool Research Articles Childhood Langerhans Cell Histiocytosis [ SDV ] Life Sciences [q-bio] business.industry Mediastinum Infant Hematology medicine.disease 3. Good health Histiocytosis Histiocytosis Langerhans-Cell medicine.anatomical_structure Oncology 030220 oncology & carcinogenesis Child Preschool Pediatrics Perinatology and Child Health Female France Lymph Nodes business Cohort study Follow-Up Studies |
Zdroj: | Pediatric Blood and Cancer Pediatric Blood and Cancer, Wiley, 2013, 60 (11), pp.1759--1765. ⟨10.1002/pbc.24603⟩ Pediatric Blood and Cancer, Wiley, 2013, 60 (11), pp.1759--1765. 〈10.1002/pbc.24603〉 Pediatric Blood & Cancer |
ISSN: | 1545-5009 1545-5017 |
Popis: | Background Mediastinal involvement (MI) in Langerhans cell histiocytosis (LCH) has been rarely reported. Here, we describe the clinical, radiological, and biological presentation, and the outcome of childhood LCH with MI. Method From the French LCH register, which includes 1,423 patients aged less than 18 years, we retrieved the medical charts of patients with mediastinal enlargement detected on chest X-rays. Results Thirty-seven patients were retrieved, including 18 males; median age of diagnosis was 0.7 years, and median follow-up time was 6.2 years. The prevalence of MI varied with the age at diagnosis, ranging from 7% below 1 year old to less than 1% at >5 years. Thirteen cases (35%) were diagnosed because of MI-related symptoms, including respiratory distress (N = 4), superior venous cava syndrome (N = 2), and/or cough and polypnea (N = 10). CT scans performed in 32 cases at diagnosis showed tracheal compression (N = 5), cava thrombosis (N = 2), and/or calcification (N = 16). All patients presented multi-system disease at LCH diagnosis, and 35/37 were initially treated with vinblastine and corticosteroids. Death occurred in five cases, due to MI (N = 1) or hematological refractory involvement (N = 4). The overall 5-year survival was 87.1%, and immunodeficiency was not detected as a sequel. Conclusions MI in LCH mainly occurs in young children, and diagnosis was based on CT showing thymus enlargement and calcifications. Pediatr Blood Cancer 2013;60:1759–1765. © 2013 Wiley Periodicals, Inc. |
Databáze: | OpenAIRE |
Externí odkaz: |